News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development


 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here .

Recommended Reading

FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Internal Medicine
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Internal Medicine
Heart disease in GPA exacts high toll in year 2 and beyond
MDedge Internal Medicine
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Internal Medicine
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Internal Medicine
RFPs Available for the Study of Three Rare Diseases
MDedge Internal Medicine
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Internal Medicine
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Internal Medicine
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Internal Medicine
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Internal Medicine